WallStSmart
BDTX

Black Diamond Therapeutics Inc

NASDAQ: BDTX · HEALTHCARE · BIOTECHNOLOGY

$2.65
+3.11% today

Updated 2026-04-30

Market cap
$170.15M
P/E ratio
7.62
P/S ratio
2.43x
EPS (TTM)
$0.39
Dividend yield
—
52W range
$1 – $5
Volume
0.7M
OverviewPrice TargetsFinancialsValuationInsidersEarnings

Black Diamond Therapeutics Inc (BDTX) Financial statements

SEC filings — annual and quarterly data.

Income statementBalance sheetCash flowProfitability

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$70.00M
Revenue growth (YoY)—————————
Cost of revenue$24000.00$44000.00$47000.00$600000.00$2.22M$3.24M$437000.00$343000.00$325000.00
Gross profit$-24000.00$-44000.00$-47000.00$-600000.00$-2.22M$-3.24M$-437000.00$-343000.00$69.67M
Gross margin————————99.5%
R&D$3.45M$6.95M$21.75M$48.21M$96.83M$64.44M$58.91M$51.31M$33.56M
SG&A$666000.00$1.95M$7.58M$21.36M$30.04M$28.39M$27.11M$27.47M$16.57M
Operating income$-4.12M$-8.90M$-8.90M$-69.57M$-126.87M$-92.83M$-86.46M$-78.78M$19.87M
Operating margin————————28.4%
EBITDA$-4.09M$-8.89M$-29.29M$-66.65M$-126.67M$-92.32M$-86.02M$-78.44M$20.20M
EBITDA margin————————28.8%
EBIT$-4.12M$-8.93M$-29.33M$-67.25M$-126.87M$-92.83M$-86.46M$-78.78M$19.87M
Interest expense$65000.00$0.00$0.00$1000.00$1.28M$3.91M———
Income tax—————————
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.60M$-8.93M$-35.26M$-67.25M$-125.60M$-91.17M$-82.44M$-69.68M$22.37M
Net income growth (YoY)—-94.1%-294.8%-90.7%-86.7%+27.4%+9.6%+15.5%+132.1%
Profit margin————————32.0%